Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15581682rdf:typepubmed:Citationlld:pubmed
pubmed-article:15581682lifeskim:mentionsumls-concept:C0042479lld:lifeskim
pubmed-article:15581682lifeskim:mentionsumls-concept:C0026454lld:lifeskim
pubmed-article:15581682lifeskim:mentionsumls-concept:C0030956lld:lifeskim
pubmed-article:15581682lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:15581682lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:15581682lifeskim:mentionsumls-concept:C0036451lld:lifeskim
pubmed-article:15581682lifeskim:mentionsumls-concept:C0563463lld:lifeskim
pubmed-article:15581682lifeskim:mentionsumls-concept:C0323788lld:lifeskim
pubmed-article:15581682pubmed:issue1lld:pubmed
pubmed-article:15581682pubmed:dateCreated2004-12-7lld:pubmed
pubmed-article:15581682pubmed:abstractTextIn the present study, crude venom of Mesobuthus gibbosus (Buthidae), a scorpion distributed all over Anatolia was isolated and purified by the Sephadex G-50 gel filtration and high pressure liquid chromatographic (HPLC) separation. Two of the five fractions (fractions 4 and 5) obtained from the Sephadex G-50 filtration and detected as lethal on mice and Musca domestica larvae in in vivo toxicity tests, were independently subjected to the HPLC separation. Only one of seven fractions (fraction 5.5*) obtained from the HPLC separation of the fraction 5 was found to be extremely lethal. Sodium dodecylsulfate polyacrylamide gel electrophoretic (SDS-PAGE) analysis of the crude venom and its chromatographic fractions demonstrated that crude venom consisted of peptides with molecular weights of 6500-210,000 Da. The neurotoxic fraction 5.5* appeared as a single band of 28,000 Da and two bands of 6200 and 22,000 Da in SDS-PAGE under non-reducing and reducing conditions, respectively, suggesting that it might consist of two chains attached by a disulfide bridge. Fractions 5 and 5.5* inhibited monoamine oxidase A (MAO-A) of rat liver reversibly and non-competitively, in a concentration-dependent manner. Fraction 5.5* appeared as a potent and specific MAO-A inhibitor with a Ki value of 0.12 mg venom proteinml(-1). The inhibitory effect of venom peptide 5.5* on MAO-A was found to be dependent on the preincubation time suggesting that the peptide binds to some site other than the substrate-binding site. Results of the present study demonstrated that M. gibbosus venom contains a peptide with specific MAO-A inhibitory activity which may be responsible for the anxiogenic effects of the scorpion venoms on animals and humans.lld:pubmed
pubmed-article:15581682pubmed:languageenglld:pubmed
pubmed-article:15581682pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15581682pubmed:citationSubsetIMlld:pubmed
pubmed-article:15581682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15581682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15581682pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15581682pubmed:statusMEDLINElld:pubmed
pubmed-article:15581682pubmed:monthJanlld:pubmed
pubmed-article:15581682pubmed:issn0041-0101lld:pubmed
pubmed-article:15581682pubmed:authorpubmed-author:TamEElld:pubmed
pubmed-article:15581682pubmed:authorpubmed-author:TümerAAlld:pubmed
pubmed-article:15581682pubmed:authorpubmed-author:WangM NMNlld:pubmed
pubmed-article:15581682pubmed:issnTypePrintlld:pubmed
pubmed-article:15581682pubmed:volume45lld:pubmed
pubmed-article:15581682pubmed:ownerNLMlld:pubmed
pubmed-article:15581682pubmed:authorsCompleteYlld:pubmed
pubmed-article:15581682pubmed:pagination43-52lld:pubmed
pubmed-article:15581682pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:meshHeadingpubmed-meshheading:15581682...lld:pubmed
pubmed-article:15581682pubmed:year2005lld:pubmed
pubmed-article:15581682pubmed:articleTitleMonoamine oxidase inhibitory activities of the scorpion Mesobuthus gibbosus (Buthidae) venom peptides.lld:pubmed
pubmed-article:15581682pubmed:affiliationDepartment of Biochemistry, Faculty of Pharmacy, Hacettepe University, Ankara 06100, Turkey. gulberk@hacettepe.edu.trlld:pubmed
pubmed-article:15581682pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15581682pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed